Virus Antibody Testing Kalamazoo Mi

Lab Reagents

Human IgG antibody Laboratories manufactures the virus antibody testing kalamazoo mi reagents distributed by Genprice. The Virus Antibody Testing Kalamazoo Mi reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact virus Antibody. Other Virus products are available in stock. Specificity: Virus Category: Antibody Group: Testing Kalamazoo

Testing Kalamazoo information

MI-136

B6166-10 10 mg
EUR 373
Description: IC50: 31 nMMI-136 is a menin-MLL interaction inhibitor.Chromosomal translocations regulating mixed lineage leukemia gene (MLL) can result in the acute leukemias resistant to therapy.

MI-136

B6166-25 25 mg
EUR 757
Description: IC50: 31 nMMI-136 is a menin-MLL interaction inhibitor.Chromosomal translocations regulating mixed lineage leukemia gene (MLL) can result in the acute leukemias resistant to therapy.

MI-136

B6166-5 5 mg
EUR 232
Description: IC50: 31 nMMI-136 is a menin-MLL interaction inhibitor.Chromosomal translocations regulating mixed lineage leukemia gene (MLL) can result in the acute leukemias resistant to therapy.

MI-503

HY-16925 50mg
EUR 1347

MI-773

HY-17493 10mM/1mL
EUR 272

MI-136

HY-19319 10mM/1mL
EUR 214

MI-463

HY-19809 10mM/1mL
EUR 271

MI-538

HY-19810 10mg
EUR 628

MI-1061

HY-125858 5mg
EUR 1175

MI-3

HY-15223 5mg
EUR 229

Mi-2

abx184228-5mg 5 mg
EUR 551
  • Shipped within 1-2 weeks.

MI-192

20-abx186686
  • EUR 704.00
  • EUR 230.00
  • EUR 467.00
  • 10 mg
  • 1 mg
  • 5 mg
  • Shipped within 1-2 weeks.

MI-773

9610-1
EUR 142

MI-773

9610-5
EUR 262

MI-2

A3602-10 10 mg
EUR 282
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2

A3602-200 200 mg
EUR 1558
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

MI-2

A3602-5 5 mg
EUR 212
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).